5 ACA trends to watch

The latest stories trending on MedCity News.

Editor's Pick

Top Story Oliver Wyman: 5 ACA Trends To Watch Over the Next Decade A recent Oliver Wyman report laid out five Affordable Care Act trends to watch, including the rise of ICHRAs and the need for a "seamless member experience." Sponsored Content Using Informed Decision-Making to Reduce Staff Burnout and Transform Your Health System's Productivity Presented by Care Logistics and MedCity News In a recent webinar, Dr. Christopher Newman of Mary Washington Healthcare discussed how utilizing the principles of informed awareness has transformed staff experience and facilitated a more productive, efficient, and engaged workforce. Read more here Check Out Our Confirmed Speakers Join us at INVEST 2024 for less than a latte a day (that's what you tell your boss) and connect with the very best in healthcare. Secure Your Savings

Featured News

Report: Improving Health Equity is a Top-10 Goal for Most Healthcare Execs in 2024 A recent Deloitte report found that improving health equity is a top-10 goal for 83% of life sciences and healthcare C-suite executives in 2024. The report also laid out factors that will likely influence health equity in 2024, including AI. Longboard Pharma Trial Data Show How It Could Stand Out in the Epilepsy Field Longboard Pharmaceuticals' epilepsy drug candidate bexicaserin met the main efficacy goal of its Phase 1b/2a study along with safety data suggesting a potential edge over current treatments. With Longboard now preparing to advance to Phase 3 testing, its stock price soared more than 300%. Private Equity Ownership Leads to Worse Patient Outcomes at Hospitals, Study Shows Yet another study has been published showing that patients receiving care at PE-owned hospitals experienced a higher rate of hospital-acquired adverse events, like infections and falls, than patients receiving care at hospitals that are not PE-owned. The research comes as concerns about PE-owned hospitals are intensifying — from leaders both within and outside of the healthcare industry. Novartis Returns to Voyager Therapeutics to Reach New Gene Therapy Destinations Novartis is paying Voyager Therapeutics $100 million up front to collaborate on gene therapies for Huntington's disease and spinal muscular atrophy. The deal builds on a relationship the companies started in 2022. Are Rare Brain Diseases the Next Commercial Frontier for Gene Therapy? The biggest trend in gene therapy development is the potential of several treatments for rare neurological diseases to move from the bench to the bedside.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Sarah Jones, Chief Outcomes Officer at B.well Connected Health In this episode, Senior Reporter Katie Adams explores some executive hires and departures that recently took place in the healthcare sector, as well as layoffs affecting the industry. We also hear from Sarah Jones, who just became chief outcomes officer at B.well Connected Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe